Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Zhonghe Headway Bio-Sci & Tech is a leading Chinese biotechnology company specializing in the development and manufacturing of stable isotope-labeled diagnostic products. The company is a global pioneer in Urea Breath Test (UBT) technology, providing non-invasive 13C and 14C breath test kits and specialized detection instruments for Helicobacter pylori infection. As a core subsidiary of China Isotope & Radiation Corporation (CIRC) under the China National Nuclear Corporation (CNNC), it maintains a dominant market share in China and exports to over 80 countries. Their product portfolio is essential for gastroenterology, supporting large-scale screening for gastric diseases and monitoring treatment efficacy. The company operates high-standard GMP manufacturing facilities and continues to innovate in the field of breath-based diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Zhonghe Headway Bio Sci & Tech.